Key Links

Keylinks Right Menu 

Licensure Key Links

Keylinks Licensure

CDC has simplified COVID-19 vaccine recommendations for most people including additional doses for certain higher risk populations.

CDC actions follow an earlier recommendation by the U.S. Food and Drug Administration that amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines.

With the authorization, the fact sheets have been updated and consolidated for the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Each vaccine now has one fact sheet for healthcare providers and one fact sheet for recipients and caregivers, rather than different fact sheets for the various authorized age groups.

 for different age groups for both Moderna and Pfizer vaccines at the end of this message.

Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States

are expected to be updated soon at this link.

LDH reminds providers to report possible vaccine-related adverse events to the FDA/CDC Vaccine Adverse Event Reporting System (VAERS) at 

Any possible severe adverse events (those resulting in hospitalization, death, or persistent disability) should be immediately reported to the LDH Office Public Health (OPH) Infectious Disease/Epidemiology Hotline at 1-800-256-2748.